Kamen Robert
Insider CIK 1693540 · JNCE Director · NTGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 10,840 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 13,550 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 20,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | U Tender | 2023-05-03 | 2023-05-04 | 33,875 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | U Tender | 2023-05-03 | 2023-05-04 | 60,975 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-06-24 | 2022-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-06-18 | 2021-06-22 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-07-02 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-06-29 | 13,550 | — | $0 | 13,550 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 18,500 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 14,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 18,500 | — | $0 | 18,500 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-13 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 13,550 | — | $0 | 13,550 | SEC↗ |